Starbucks names Laxman Narasimhan as new CEO, starting in April

Starbucks names Laxman Narasimhan as new CEO, starting in April


Starbucks' new CEO Laxman Narasimhan takes helm in April 2023

Starbucks on Thursday named Laxman Narasimhan as its next chief executive officer.

Narasimhan most recently served as CEO of health and hygiene company Reckitt, which owns brands such as Lysol, Durex and Mucinex. He announced earlier Thursday he was stepping down from that role. He’ll join Starbucks in October, learning about the company and its reinvention plan, before assuming the top job in April.

related investing news

New Starbucks CEO has exactly the kind of consumer experience the coffee chain needs

CNBC Investing Club
New Starbucks CEO has exactly the kind of consumer experience the coffee chain needs

Until then, Howard Schultz will continue as interim CEO of the coffee chain he grew into a global giant. Schultz will remain on Starbucks’ board after Narasimhan succeeds him.

Schultz has been at the helm since April, when his handpicked successor Kevin Johnson retired after five years on the job. Schultz returned to the company as its interim CEO, earning just $1 for his salary. In the meantime, Schultz and the Starbucks board hunted for a long-term successor, with the intention of announcing the new CEO in the fall. (The coffee chain brought back the Pumpkin Spice Latte and other fall menu items on Tuesday.)

Schultz has previously said that he wants to reinvent the employee, customer and store experience to reckon with how the world has changed since the pandemic. The company is holding an investor day on Sept. 13 in Seattle, where it’s expected to unveil more details about the bold changes it plans to make.

Starbucks said in a news release that Schultz will remain “closely involved” with the plan and act as an advisor to Narasimhan.

Narasimhan previously worked at PepsiCo, serving as its global chief commercial officer among other roles. Prior to working at the food and beverage giant, he was a senior partner at McKinsey.

As CEO, he’ll have to tackle a number of challenges. In its home market, Starbucks is facing a union push, with more than 200 stores in the U.S. voting to organize under Workers United. The battle has resulted in negative headlines and legal battles. Inflation hasn’t hurt sales yet, but it has pushed menu prices higher. And China, its second-largest market, is struggling to bounce back from the pandemic, hampered by the country’s zero Covid policy.

“His deep, hands-on experience driving strategic transformations at global consumer-facing businesses makes him the ideal choice to accelerate Starbucks growth and capture the opportunities ahead of us,” Starbucks board chair Mellody Hobson said in a statement.



Source

How Domino’s is trying to double its business during a rough patch for big pizza rivals
Business

How Domino’s is trying to double its business during a rough patch for big pizza rivals

In this photo illustration, a Domino’s pizza sits in a take-out box on July 21, 2025 in Miami, Florida. Joe Raedle | Getty Images Domino’s Pizza shares climbed on a Monday after the company posted a better-than-expected quarter and laid out ambitious growth plans. The strong performance came as the pizza chain said it saw […]

Read More
Mortgage rates just dropped below 6%, matching lowest level since 2022
Business

Mortgage rates just dropped below 6%, matching lowest level since 2022

A stock market sell-off had investors rushing to the relative safety of the bond market Monday morning, causing yields to drop and mortgage rates to follow. The average rate on the popular 30-year fixed mortgage fell to 5.99% on Monday, according to Mortgage News Daily, matching its lowest levels since 2022. Last year at this […]

Read More
Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen
Business

Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March 28, 2024. Shelby Knowles | Bloomberg | Getty Images Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month’s worth of doses in a single pen. Cash-paying patients can […]

Read More